The regulator argues that CME cannot challenge its approval of Kalshi’s Bitcoin perpetual contract without showing concrete financial harm.
The regulator argues that CME cannot challenge its approval of Kalshi’s Bitcoin perpetual contract without showing concrete financial harm.